Brandon Walsh

Author PubWeight™ 13.91^‹?›

Rank	Title	Journal	Year	PubWeight™‹?›
1	Efficacy and safety of exenatide once weekly versus sitagliptin or pioglitazone as an adjunct to metformin for treatment of type 2 diabetes (DURATION-2): a randomised trial.	Lancet	2010	3.56
2	DURATION-1: exenatide once weekly produces sustained glycemic control and weight loss over 52 weeks.	Diabetes Care	2010	2.45
3	Reduced oxidative power but unchanged antioxidative capacity in skeletal muscle from aged humans.	Pflugers Arch	2003	1.44
4	Pharmacokinetics and pharmacodynamics of exenatide extended-release after single and multiple dosing.	Clin Pharmacokinet	2011	1.33
5	Amylin-mediated restoration of leptin responsiveness in diet-induced obesity: magnitude and mechanisms.	Endocrinology	2008	1.23
6	Exenatide once weekly treatment maintained improvements in glycemic control and weight loss over 2 years.	BMC Endocr Disord	2011	1.04
7	Effects of acute creatine kinase inhibition on metabolism and tension development in isolated single myocytes.	J Appl Physiol (1985)	2004	0.90
8	Effect of physiological levels of caffeine on Ca2+ handling and fatigue development in Xenopus isolated single myofibers.	Am J Physiol Regul Integr Comp Physiol	2009	0.80
9	Relationship between intracellular PO2 recovery kinetics and fatigability in isolated single frog myocytes.	J Appl Physiol (1985)	2005	0.79
10	Exenatide once-weekly clinical development: safety and efficacy across a range of background therapies.	Diabetes Technol Ther	2011	0.79